Changes in venous function after foam sclerotherapy of varicose veins

Phlebology

Volumn 24, Issue 4, 2009, Pages 145-150

  Brunken, A ^a   Rabe, E ^b   Pannier, F ^c  

^a Praxis für Gefäßmedizin ^*  (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Foam; Haemodynamics; Polidocanol; Sclerotherapy; Varicose veins

Indexed keywords

POLIDOCANOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOAM; HUMAN; HYPERPIGMENTATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHLEBITIS; PHOTOELECTRIC PLETHYSMOGRAPHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; SCLEROTHERAPY; STRAIN GAUGE TRANSDUCER; TREATMENT RESPONSE; VARICOSIS; VEIN BLOOD FLOW;

AGED; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TREATMENT OUTCOME; VARICOSE VEINS; VEINS;

EID: 67749131165     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.008068     Document Type: Article

References (25)

1. Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004;30:687-693
2. Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la sclérothérapie: noveaux produits. Scléros Phlébol 1997;50:181-191
3. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-18 (Pubitemid 35231053)
4. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002;28:11-15 (Pubitemid 34101573)
5. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;30:6-12 (Pubitemid 38174021)
6. Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy, 28-30 April 2006, Tegernsee, Germany. Vasa 2008;37(Suppl. 71): 1-32
7. Rabe E, Pannier F, Gerlach H, Breu FX, Guggenbichler S, Wollmann JC. Leitlinie: Skelrosierungsbehandlung der Varikose. Phlebologie 2008;38:27-34
8. Eklof B, Rutherford RB, Bergan JJ, et al. American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-1252
9. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60 (Pubitemid 32107620)
10. Weiss RA. Evaluation of the venous system by Doppler ultrasound and photoplethysmography or light reflection rheography before sclerotherapy. Semin Dermatol 1993;12:78-87
11. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-583
12. Darke SG, Baker SJA. Ultrasound-guided foam slcerotherapy for the treatment of varicose veins. Br J Surg 2006;93:969-974 (Pubitemid 44214847)
13. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94:925-936 (Pubitemid 47236534)
14. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007;26:22-28
15. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004;30:1386-1390 (Pubitemid 39552228)
16. Ceulen RPM, Essers SMAP, Bullens-Goessens YIJM, Sommer A. Ergebnisse und Nebenwirkungen ultraschallassistierter Sklerotherapie bei der Behandlung der Vena saphena magna mit Polidocanolschaum: 1% vs. 3%. Ergebnisse einer randomisierten, kontrollierten Studie mit 2,5 Jahren Follow-up. Vasomed 2007;19:18-19
17. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vas Endovasc Surg 2007;33:116-121 (Pubitemid 44872674)
18. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endocvasc Surg 2008;35:238-245 (Pubitemid 351163086)
19. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-1175 (Pubitemid 38009913)
20. Alós J, Carreno P, Lopez JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-107 (Pubitemid 43024991)
21. Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006;31:93-100 (Pubitemid 43024990)
22. Wright D, Gobin JP, Bradbury AW, et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-190 (Pubitemid 44913249)
23. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. J Endovasc Ther 2006;13:357-364 (Pubitemid 44775212)
24. Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.:CD001732
25. Neglén P, Einarsson E, Eklöf B. The functional long-term value of different types of treatment for saphenous vein incompetence. J Cardiovasc Surg 1993;34:295-301 (Pubitemid 24001877)